Leal Health
New York
About Leal Health
Leal Health, formerly known as Trialjectory, is a patient-first, AI-powered treatment decision support platform dedicated to improving cancer care. Working directly with patients, healthcare providers and pharmaceutical companies, Leal democratizes access to advanced cancer treatment and empowers the pharmaceutical and biotech industry to execute patient-centric clinical trials. The Company has been recognized by TIME as one of "The 100 Best Inventions of 2020" and named an honoree in the AI and data category for Fast Company's "2021 World-Changing Ideas Awards." For more information, please visit www.leal.health, and follow the Company on Facebook and LinkedIn.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $27.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2022)
- Website: leal.health
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Clinical Trials, Communities, Health Care, Marketplace
Social Profiles
Canonical: https://fsome.com/organization/leal-health-56853 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.